Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Djoussé, L.
Right arrow Articles by Myers, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Djoussé, L.
Right arrow Articles by Myers, R. H.
Related Collections
Right arrow Nutritional
Right arrow All Movement Disorders
Right arrow Huntington's disease
Right arrow Trinucleotide repeat diseases

Neurology 2002;59:1325-1330
© 2002 American Academy of Neurology

Weight loss in early stage of Huntington’s disease

L. Djoussé, MD DSc, B. Knowlton, L. A. Cupples, PhD, K. Marder, MD, I. Shoulson, MD and R. H. Myers, PhD for the investigators of the Huntington Study Group*

From the Evans Department of Medicine (Dr. Djoussé), Section of Preventive Medicine and Epidemiology, and Department of Neurology (B. Knowlton and Dr. Myers), Boston University School of Medicine; Department of Biostatistics (Dr. Cupples), Boston University School of Public Health, MA; Department of Neurology (Dr. Marder), Columbia University College of Physicians and Surgeons, New York, NY; and the Department of Neurology (Dr. Shoulson), University of Rochester, NY.

Address correspondence and reprint requests to Dr. Richard H. Myers, Department of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118; e-mail: rmyers{at}bu.edu

Background: Huntington’s disease (HD) is an autosomal dominant disease with neurologic manifestations. In transgenic mouse models of HD, weight loss is recognized as a feature associated with the disease onset. It is unclear whether a similar pattern occurs in humans.

Methods: Data from the Huntington Study Group were used to evaluate whether HD is associated with lower body mass index (BMI) at the earliest stage of the disease. There were 361 case subjects in whom HD had been diagnosed with an independence scale rating of 100 (no special care needed), a total functional capacity score of >=11, and HD duration of <4 years. For each case subject, five sex- and age-matched control subjects were selected from the National Heart, Lung, and Blood Institute Family Heart Study or the Framingham Offspring Study.

Results: Among case subjects, neither disease duration, nor dystonia, nor chorea score was significantly associated with BMI. BMI was significantly lower among case than among control subjects. Among men, age-adjusted BMI (±SE) was 25.90 ± 0.34 kg/m2 for case subjects with HD and 27.68 ± 0.16 kg/m2 for control subjects. Among women, corresponding values were 24.34 ± 0.43 for case subjects with HD and 26.63 ± 0.21 kg/m2 for control subjects.

Conclusions: At an early stage of the disease, subjects with Huntington’s disease had lower body mass index than matched controls from the general population. The cause of weight loss is unknown but the parallel to observations in Huntington’s disease transgenic mice suggests that it is a significant hallmark of Huntington’s disease gene expression.




This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
C. Zabel, L. Mao, B. Woodman, M. Rohe, M. A. Wacker, Y. Klare, A. Koppelstatter, G. Nebrich, O. Klein, S. Grams, et al.
A Large Number of Protein Expression Changes Occur Early in Life and Precede Phenotype Onset in a Mouse Model for Huntington Disease
Mol. Cell. Proteomics, April 1, 2009; 8(4): 720 - 734.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Phan, M. A. Hickey, P. Zhang, M.-F. Chesselet, and K. Reue
Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models
Hum. Mol. Genet., March 15, 2009; 18(6): 1006 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. A. Aziz, J.M.M. van der Burg, G. B. Landwehrmeyer, P. Brundin, T. Stijnen, EHDI Study Group, and R. A.C. Roos
Weight loss in Huntington disease increases with higher CAG repeat number
Neurology, November 4, 2008; 71(19): 1506 - 1513.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
N. M. Lalic, J. Maric, M. Svetel, A. Jotic, E. Stefanova, K. Lalic, N. Dragasevic, T. Milicic, L. Lukic, and V. S. Kostic
Glucose Homeostasis in Huntington Disease: Abnormalities in Insulin Sensitivity and Early-Phase Insulin Secretion
Arch Neurol, April 1, 2008; 65(4): 476 - 480.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Shao and M. I. Diamond
Polyglutamine diseases: emerging concepts in pathogenesis and therapy
Hum. Mol. Genet., October 15, 2007; 16(R2): R115 - R123.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
K. Wojaczynska-Stanek, D. Adamek, E. Marszal, and D. Hoffman-Zacharska
Huntington Disease in a 9-Year-Old Boy: Clinical Course and Neuropathologic Examination
J Child Neurol, December 1, 2006; 21(12): 1068 - 1073.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
M. Bjorkqvist, A. Petersen, K. Bacos, J. Isaacs, P. Norlen, J. Gil, N. Popovic, F. Sundler, G. P. Bates, S. J. Tabrizi, et al.
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
Hum. Mol. Genet., May 15, 2006; 15(10): 1713 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. M. Van Raamsdonk, W. T. Gibson, J. Pearson, Z. Murphy, G. Lu, B. R. Leavitt, and M. R. Hayden
Body weight is modulated by levels of full-length Huntingtin
Hum. Mol. Genet., May 1, 2006; 15(9): 1513 - 1523.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
B. R. Underwood, D. Broadhurst, W. B. Dunn, D. I. Ellis, A. W. Michell, C. Vacher, D. E. Mosedale, D. B. Kell, R. A. Barker, D. J. Grainger, et al.
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
Brain, April 1, 2006; 129(4): 877 - 886.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. D. Strand, A. K. Aragaki, D. Shaw, T. Bird, J. Holton, C. Turner, S. J. Tapscott, S. J. Tabrizi, A. H. Schapira, C. Kooperberg, et al.
Gene expression in Huntington's disease skeletal muscle: a potential biomarker
Hum. Mol. Genet., July 1, 2005; 14(13): 1863 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. M Gaba, K. Zhang, K. Marder, C. B Moskowitz, P. Werner, and C. N Boozer
Energy balance in early-stage Huntington disease
Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1335 - 1341.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Q. Harper, P. D. Staber, X. He, S. L. Eliason, I. H. Martins, Q. Mao, L. Yang, R. M. Kotin, H. L. Paulson, and B. L. Davidson
From the Cover: RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
PNAS, April 19, 2005; 102(16): 5820 - 5825.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J M Hamilton, T Wolfson, G M Peavy, M W Jacobson, and J Corey-Bloom
Rate and correlates of weight change in Huntington's disease
J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 209 - 212.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.